Your browser doesn't support javascript.
loading
Exploring the Effects and Potential Mechanisms of Hesperidin for the Treatment of CPT-11-Induced Diarrhea: Network Pharmacology, Molecular Docking, and Experimental Validation.
Shu, Xinyao; Xu, Ruitong; Xiong, Peiyu; Liu, Junyu; Zhou, Zubing; Shen, Tao; Zhang, Xiaobo.
Affiliation
  • Shu X; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Xu R; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Xiong P; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Liu J; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Zhou Z; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Shen T; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Zhang X; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Int J Mol Sci ; 25(17)2024 Aug 28.
Article in En | MEDLINE | ID: mdl-39273257
ABSTRACT
Chemotherapy-induced diarrhea (CID) is a potentially serious side effect that often occurs during anticancer therapy and is caused by the toxic effects of chemotherapeutic drugs on the gastrointestinal tract, resulting in increased frequency of bowel movements and fluid contents. Among these agents, irinotecan (CPT-11) is most commonly associated with CID. Hesperidin (HPD), a flavonoid glycoside found predominantly in citrus fruits, has anti-oxidation properties and anti-inflammation properties that may benefit CID management. Nevertheless, its potential mechanism is still uncertain. In this study, we firstly evaluated the pharmacodynamics of HPD for the treatment of CID in a mouse model, then used network pharmacology and molecular docking methods to excavate the mechanism of HPD in relieving CID, and finally further proved the predicted mechanism through molecular biology experiments. The results demonstrate that HPD significantly alleviated diarrhea, weight loss, colonic pathological damage, oxidative stress, and inflammation in CID mice. In addition, 74 potential targets for HPD intervention in CID were verified by network pharmacology, with the top 10 key targets being AKT1, CASP3, ALB, EGFR, HSP90AA1, MMP9, ESR1, ANXA5, PPARG, and IGF1. The Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed that the PI3K-Akt pathway, FoxO pathway, MAPK pathway, TNF pathway, and Ras pathway were most relevant to the HPD potential treatment of CID genes. The molecular docking results showed that HPD had good binding to seven apoptosis-related targets, including AKT1, ANXA5, CASP3, HSP90AA1, IGF1, MMP9, and PPARG. Moreover, we verified apoptosis by TdT-mediated dUTP nick-end labeling (TUNEL) staining and immunohistochemistry, and the hypothesis about the proteins above was further verified by Western blotting in vivo experiments. Overall, this study elucidates the potential and underlying mechanisms of HPD in alleviating CID.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diarrhea / Molecular Docking Simulation / Irinotecan / Network Pharmacology / Hesperidin Limits: Animals Language: En Journal: Int J Mol Sci Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diarrhea / Molecular Docking Simulation / Irinotecan / Network Pharmacology / Hesperidin Limits: Animals Language: En Journal: Int J Mol Sci Year: 2024 Document type: Article Affiliation country: Country of publication: